Antidepressant phenotype by inhibiting the phospholipase Cβ1 - Protein kinase Cγ pathway in the forced swim test

Neuropharmacology

Volumn 60, Issue 6, 2011, Pages 937-943

  Galeotti, Nicoletta ^a   Ghelardini, Carla ^a  

^a Department of Preclinical and Clinical Pharmacology ^*  (Italy)

Author keywords

Antidepressant; Depression; Forced swimming test; Phospholipase C; Protein kinase C

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; ANTISENSE OLIGONUCLEOTIDE; CALPHOSTIN C; CHELERYTHRINE; NEOMYCIN; PHOSPHOLIPASE C BETA1; PROTEIN KINASE C GAMMA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPRESSION; ENZYME ACTIVITY; ENZYME INHIBITION; FORCED SWIMMING TEST; IMMOBILIZATION; LOCOMOTION; MALE; MOTOR COORDINATION; MOUSE; NEUROMODULATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIDEPRESSIVE AGENTS; BENZOPHENANTHRIDINES; DEPRESSION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; ESTRENES; GENE KNOCKDOWN TECHNIQUES; MALE; MICE; MOTOR ACTIVITY; NAPHTHALENES; NEOMYCIN; OLIGONUCLEOTIDES, ANTISENSE; PHENOTYPE; PHOSPHOLIPASE C BETA; PROTEIN KINASE C; PSYCHOMOTOR PERFORMANCE; PYRROLIDINONES; SIGNAL TRANSDUCTION; SWIMMING;

EID: 79952444121     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2011.01.037     Document Type: Article

References (52)

1. A. Apter, D. Gothelf, I. Orbach, R. Weizman, G. Ratzoni, D. Har-Even, and S. Tyano Correlation of suicidal and violent behavior in different diagnostic categories in hospitalized adolescent patients J. Am. Acad. Child. Adolesc. Psychiatry 34 1995 912 918
2. M.J. Berridge, and R.F. Irvine Inositol phosphatase and cell signalling Nature 341 1989 197 205
3. J.E. Bleasdale, N.R. Thakur, R.S. Gremban, G.L. Bundy, F.A. Fitzpatrick, R.J. Smith, and S. Bunting Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils J. Pharmacol. Exp. Ther. 255 1990 756 768
4. J.D. Bremner Structural changes in the brain in depression and relationship to symptom recurrence CNS Spectr. 7 2002 135 139
5. D.A. Brent, D.J. Kolko, M.E. Wartella, M.B. Boylan, G. Moritz, M. Baugher, and J.P. Zelenak Adolescent psychiatric inpatients' risk of suicide attempt at 6-month follow-up J. Am. Acad. Child. Adolesc. Psychiatry 32 1993 95 105 (Pubitemid 23052908)
6. A.S. Brown, A.G. Mallinger, and L.C. Renbaum Elevated platelet membrane phosphatidylinositol-4,5-bisphosphate in bipolar mania Am. J. Psychiatry 150 1993 1252 1254 (Pubitemid 23218911)
7. M.A. Coull, S. Lowther, C.L. Katona, and R.W. Horton Post-mortem studies of brain phosphatidylinositol hydrolysis in depression and the effect of antidepressant treatment Int. J. Neuropsychopharmacol. 3 2000 109 115 (Pubitemid 30429354)
8. W.C. Drevets, J.L. Price, J.R. Simpson, R.D. Todd, T. Reich, M. Vannier, and M.E. Raichle Subgenual prefrontal cortex abnormalities in mood disorders Nature 386 1997 824 827 (Pubitemid 27181254)
9. Y. Dwivedi, A.K. Agrawal, H.S. Rizavi, and G.N. Pandey Antidepressants reduce phosphoinositide-specific phospholipase C (PI-PLC) activity and the mRNA and protein expression of selective PLC beta 1 isozyme in rat brain Neuropharmacology 43 2002 1269 1279 (Pubitemid 36084437)
10. 3H] inositol 1,4,5-trisphosphate binding sites and expressed inositol 1,4,5-trisphosphate receptor protein level in platelets of depressed patients Psychopharmacology (Berl) 138 1998 47 54 (Pubitemid 28319047)
11. L.E. Dyck, and A.A. Boulton Effects of antidepressant drugs on inositol phospholipid hydrolysis in rat cerebral cortical slices Neurochem. Res. 14 1989 1047 1052 (Pubitemid 20013033)
12. H. Einat, P. Yuan, S.T. Szabo, S. Dogra, and H.K. Manji Protein kinase C inhibition by tamoxifen antagonizes manic-like behavior in rats: implications for the development of novel therapeutics for bipolar disorder Neuropsychobiology 55 2007 123 131 (Pubitemid 47525230)
13. G.J. Emslie, A.J. Rush, W.A. Weinberg, R.A. Kowatch, C.W. Hughes, T. Carmody, and J. Rintelmann A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression Arch. Gen. Psychiatry 54 1997 1031 1037 (Pubitemid 27476099)
14. E. Friedman, and H.Y. Wang Receptor-mediated activation of G proteins is increased in postmortem brains of bipolar affective disorder subjects J. Neurochem. 67 1996 1145 1152 (Pubitemid 26277927)
15. 3 pathway is involved in muscarinic antinociception Neuropsychopharmacology 28 2003 888 897
16. N. Galeotti, G.B. Stefano, M. Guarna, E. Bianchi, and C. Ghelardini Signalling pathway of morphine induced acute hyperalgesia in mice Pain 123 2006 294 305
17. P. Hazell, D. O'Connell, D. Heathcote, J. Robertson, and D. Henry Efficacy of tricyclic drugs in treating child and adolescent depression: a meta-analysis Br. Med. J. 310 1995 897 901
18. J.M. Herbert, J.M. Augereau, J. Gleye, and J.P. Maffrand Chelerythrine is a potent and specific inhibitor of protein kinase C Biochem. Biophys. Res. Comm. 172 1990 993 999
19. R.S. Jope, L. Song, P.P. Li, L.T. Young, S.J. Kish, M.A. Pacheco, and J.J. Warsh The phosphoinositide signal transduction system is impaired in bipolar affective disorder brain J. Neurochem. 66 1996 2402 2409 (Pubitemid 26159075)
20. F. Karege, P. Bovier, W. Rudolph, and J.M. Gaillard Platelet phosphoinositide signaling system: an over-stimulated pathway in depression Biol. Psychiatry 39 1996 679 702
21. E. Kobayashi, H. Nakano, M. Morimoto, and T. Tamaoki Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C Biochem. Biophys. Res. Comm. 159 1989 548 553 (Pubitemid 19089785)
22. C.D. Mann, T.B. Vu, and P.D. Hrdina Protein kinase C in rat brain cortex and hippocampus: effect of repeated administration of fluoxetine and desipramine Br. J. Pharmacol. 115 1995 595 600
23. D. Marazziti, M. Catena Dell'Osso, G. Consoli, and S. Baroni Second messenger modulation: a novel target of future antidepressants? Curr. Med. Chem. 16 2009 4679 4690
24. q/11 immunoreactivity in postmortem occipital cortex from patients with bipolar affective disorders Biol. Psychiatry 41 1997 649 656 (Pubitemid 27157756)
25. S. Morishita, S. Aoki, and S. Watanabe Different effect of desipramine on protein kinase C in platelets between bipolar and major depressive disorders Psychiatry Clin. Neurosci. 53 1999 11 15 (Pubitemid 29173859)
26. S. Morishita, and S. Watanabe Effect of the tricyclic antidepressant desipramine on protein kinase C in rat brain and rabbit platelets in vitro Psychiatry Clin. Neurosci. 51 1997 249 252 (Pubitemid 27362559)
27. Y. Nishizuka Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C Science 258 1992 607 613
28. G.N. Pandey, Y. Dwivedi, R. Kumari, and P.G. Janicak Protein kinase C in platelets of depressed patients Biol. Psychiatry 44 1998 909 911 (Pubitemid 28520229)
29. G.N. Pandey, Y. Dwivedi, S.C. Pandey, S.S. Teas, R.R. Conley, R.C. Roberts, and C.A. Tamminga Low phosphoinositide-specific phospholipase C activity and expression of phospholipase C beta1 protein in the prefrontal cortex of teenage suicide subjects Am. J. Psychiatry 156 1999 1895 1901
30. G.N. Pandey, Y. Dwivedi, H.S. Rizavi, X. Ren, and R.R. Conley Decreased catalytic activity and expression of protein kinase C isozymes in teenage suicide victims: a post-mortem brain study Arch. Gen. Psychiatry 61 2004 685 693 (Pubitemid 38890802)
31. G.N. Pandey, Y. Dwivedim, J. Sridhara Rao, X. Ren, P.G. Janicak, and R. Sharma Protein kinase C and phospholipase C activity and expression of their specific isozymes is decreased and expression of MARCKS is increased in platelets of bipolar but not in unipolar patients Neuropsychopharmacology 26 2002 216 228 (Pubitemid 34093084)
32. G.N. Pandey, S.C. Pandey, and J.M. Davis Effect of desipramine on inositol phosphate formation and inositol phospholipids in rat brain and human platelets Psychopharmacol. Bull. 27 1991 255 261
33. B. Petit-Demouliere, F. Chenu, and M. Bourin Forced swimming test in mice: a review of antidepressant activity Psychopharmacology 177 2005 245 255 (Pubitemid 40137284)
34. M. Phillippe Neomycin inhibition of hormone-stimulated smooth muscle contractions in myometrial tissue Biochem. Biophys. Res. Comm. 205 1994 245 250 (Pubitemid 24381617)
35. R.D. Porsolt, A. Bertin, and M. Jalfre Behavioural despair in mice: a primary screening test for antidepressants Arch. Int. Pharmacodyn. 229 1977 327 336 (Pubitemid 8225714)
36. M.J. Rebecchi, and S.N. Pentyala Structure, function and control of phosphoinositide-specific phospholipase C Physiol. Rev. 80 2000 1291 1335
37. S.G. Rhee Regulation of phosphoinositide-specific phospholipase C Annu. Rev. Biochem. 70 2001 281 312 (Pubitemid 32662212)
38. C.A. Ross, M.W. MacCumber, C.E. Glatt, and S.H. Snyder Brain phospholipase C isozymes: differential mRNA localizations by in situ hybridization Proc. Natl. Acad. Sci. USA 86 1989 2923 2927 (Pubitemid 19112649)
39. P. Sabioni, I.P. Baretta, E.M. Ninomiya, L. Gustafson, A.L. Rodrigues, and R. Andreatini The antimanic-like effect of tamoxifen: behavioural comparison with other PKC-inhibiting and antiestrogenic drugs Prog. Neuropsychopharmacol. Biol. Psychiatry 32 2008 1927 1931
40. N. Saito, U. Kikkawa, Y. Nishizuka, and C. Tanaka Distribution of protein kinase C-like immunoreactive neurons in rat brain J. Neurosci. 8 1988 369 382 (Pubitemid 18078066)
41. P. Sanchez-Blazquez, and J. Garzon Delta opioid subtypes activates inositol-signaling pathways in the production of antinociception J. Pharmacol. Exp. Ther. 285 1998 820 827 (Pubitemid 28237467)
42. P.H. Silverstone, B.M. McGrath, and H. Kim Bipolar disorders and myo-inositol: a review of the magnetic resonance spectroscopy findings Bip. Disord. 7 2005 1 10 (Pubitemid 40227831)
43. R.J. Smith, L.M. Sam, J.M. Justen, G.L. Bundy, G.A. Bala, and J.E. Bleasdale Receptor-coupled signal transduction in human polymorphonuclear neutrophils: effects of a novel inhibitor of phospholipase C-dependent processes on cell responsiveness J. Pharmacol. Exp. Ther. 253 1990 688 697 (Pubitemid 20181715)
44. J.C. Soares, C.S. Dippold, K.F. Wells, E. Frank, D.J. Kupfer, and A.G. Mallinger Increased platelet membrane phosphatidylinositol-4,5-bisphosphate in drug-free depressed bipolar patients Neurosci. Lett. 299 2001 150 152 (Pubitemid 32146366)
45. O. Tanaka, and H. Kondo Localization of mRNAs for three novel members (beta 3, beta 4 and gamma 2) of phospholipase C family in mature rat brain Neurosci. Lett. 182 1994 17 20
46. G.L. Wakdo, J. Northup, J.P. Perkins, and T.K. Harden Characterization of an altered membrane form of the beta-adrenergic receptor produced during agonist-induced desensitization J. Biol. Chem. 258 1983 13900 13908 (Pubitemid 14203798)
47. H.Y. Wang, and E. Friedman Enhanced protein kinase C activity and translocation in bipolar affective disorder brains Biol. Psychiatry 40 1996 568 575 (Pubitemid 26356388)
48. H.Y. Wang, P. Markowitz, D. Levinson, A.S. Undie, and E. Friedman Increased membrane-associated protein kinase C activity and translocation in blood platelets from bipolar affective disorder patients J. Psychiatr. Res. 33 1999 171 179 (Pubitemid 29134745)
49. K.J. Way, E. Chou, and G.L. King Identification of PKC-isoforms-specific biological actions using pharmacological approaches Trends Pharmacol. Sci. 21 2000 181 187 (Pubitemid 30243200)
50. A. Yildiz, S. Guleryuz, D.P. Ankerst, D. Ongür, and P.F. Renshaw Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen Arch. Gen. Psychiatry 65 2008 255 263 (Pubitemid 351342442)
51. 2+ oscillations in response to cholecystokinin and carbachol but not to JMV-180 in rat pancreatic acinar cells J. Biol. Chem. 267 1992 13830 13835
52. C.A. Zarate Jr., J.B. Singh, P.J. Carlson, J. Quiroz, L. Jolkovsky, D.A. Luckenbaugh, and H.K. Manji Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study Bipolar Disord. 9 2007 561 570 (Pubitemid 47365623)